METTL14 promotes lipid metabolism reprogramming and sustains nasopharyngeal carcinoma progression via enhancing m 6 A modification of ANKRD22 mRNA.
Lvyuan LiQiling TangJunshang GeDan WangYongzhen MoYijie ZhangYumin WangFang XiongQijia YanQianjin LiaoCan GuoFuyan WangMing ZhouBo XiangZhaoyang ZengLei ShiPan ChenZhaoyang ZengPublished in: Clinical and translational medicine (2024)
The identified METTL14-ANKRD22-SLC25A1 axis emerges as a promising therapeutic target for NPC, and also these molecules may serve as novel diagnostic biomarkers.
Keyphrases